Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream... see more

CSE:DOSE - Post Discussion

Rapid Dose Therapeutics Corp > This stock is cheap until the announcements...
View:
Post by Profiteer on Feb 13, 2024 2:05pm

This stock is cheap until the announcements...

The best time to get into the RDTstock is when it's cheap BEFORE the hype. It'll be too expensive after the hype.

So what are the 2 announcements that can potentially create the hype? 

1. Covid is here to stay and therefore vaccines will be needed. The company is currently involved in ongoing research with pharmaceutical companies to create vaccines that don't require expensive cold-chain distribution and won't require needles. The best part is the cost/funding of testing will be the responsiblity of the pharma companies who own the vaccines and this product is not limited to just Covid vaccines. 

2. RDT is involved in research & development with one of the world's largest tobacco manufacturers to create a new smokeless nicotine product. With 20 billion cigarettes being consumed daily worldwide, RDT would benefit from catching even a  small fraction of the market share. The only entity that could've stood in their way was a major tobacco manufacturer, but in this case, a major manufacturer is recognizing the value proposition and decided to get a head start on the competition. 

There are other projects underway, but I think these 2 in particular are exciting game-changing products. 

Check out the current edition of management's discussion & analysis.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities